MLICM
ACGN

Metropolitan Life Insurance Company (MetLife)’s Aceragen Inc ACGN Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio ACGN Stock Details ACGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-316
Closed -$79K – 2503
2018
Q1 		$79K Buy
316
+150
+90% +$41.1K ﹤0.01% 2391
2017
Q4 		$48K Buy
+166
New +$47.4K ﹤0.01% 2466
2016
Q1 		– Sell
-470
Closed -$197K – 2532
2015
Q4 		$197K Hold
470
– – ﹤0.01% 2281
2015
Q3 		$214K Buy
470
+302
+180% +$134K ﹤0.01% 2242
2015
Q2 		$85K Buy
+168
New +$77.1K ﹤0.01% 2624
2015
Q1 		– Sell
-378
Closed -$226K – 2481
2014
Q4 		$226K Buy
+378
New +$152K ﹤0.01% 2329

Other funds holding ACGN

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
N
Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s ACGN Position: Q2 2018 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Aceragen Inc (ACGN) in Q2 2018, closing a stake of 316 shares — an estimated $79K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in ACGN in Q4 2014 and held it in 6 quarters. The position peaked at $226K in Q4 2014. 93 funds tracked by Wall St. Rank hold ACGN as of Q2 2018.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Aceragen Inc position as of Q2 2018 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 316 Aceragen Inc shares in Q2 2018, an estimated $79K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Aceragen Inc in Q4 2014 and held it in 6 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Aceragen Inc position peaked at $226K in Q4 2014.
  • 93 funds tracked by Wall St. Rank held Aceragen Inc as of Q2 2018.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2018, filed 15 Aug 2018.